carbimazole has been researched along with Myasthenia Gravis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Garosi, L; Lowrie, M; Mignan, T; Targett, M | 1 |
Elston, M; Rebello, R; Sehgal, S; Wolmarans, L | 1 |
Bell, ET; James, FE; Mansfield, CS | 1 |
Datta, TK; Madiajagne, R; Shrivastava, MP | 1 |
4 other study(ies) available for carbimazole and Myasthenia Gravis
Article | Year |
---|---|
Long-term outcome of cats with acquired myasthenia gravis without evidence of a cranial mediastinal mass.
Topics: Animals; Antithyroid Agents; Carbimazole; Cat Diseases; Cats; Female; Male; Methimazole; Myasthenia Gravis; Remission, Spontaneous; Retrospective Studies | 2020 |
Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Blepharoptosis; Carbimazole; Cholinesterase Inhibitors; Female; Graves Disease; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Myasthenia Gravis; Pyridostigmine Bromide; Thyrotoxicosis; Treatment Outcome | 2017 |
Immune-mediated myasthenia gravis in a methimazole-treated cat.
Topics: Animals; Antithyroid Agents; Carbimazole; Cat Diseases; Cats; Female; Hyperthyroidism; Methimazole; Myasthenia Gravis; Pyridostigmine Bromide; Receptors, Cholinergic | 2012 |
Thyrotoxicosis with myasthenia--an unusual association.
Topics: Adult; Blepharoptosis; Carbimazole; Female; Humans; Myasthenia Gravis; Neostigmine; Prednisolone; Thyrotoxicosis | 1991 |